Document 0209 DOCN M9440209 TI Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm. DT 9404 AU Kalland KH; Szilvay AM; Langhoff E; Haukenes G; Department of Microbiology and Immunology, Gade Institute,; University of Bergen, Norway. SO J Virol. 1994 Mar;68(3):1475-85. Unique Identifier : AIDSLINE MED/94149836 AB The human immunodeficiency virus type 1 (HIV-1) Rev (regulator of virion protein expression) protein exemplifies a new type of posttranscriptional regulation. One main function of Rev is to increase the cytoplasmic expression of unspliced and incompletely spliced retroviral mRNAs from which viral structural proteins are made. In that way, Rev is essential in order to complete the retroviral life cycle. The biology of Rev in the host cell has remained elusive. In this study, a complex distribution of Rev in single cells was found. Rev was found in the cytoplasm, in a perinuclear zone, in the nucleoplasm, and in the nucleoli. In the nucleoplasm, Rev colocalized in a speckled pattern with host cell factors known to assemble on nascent transcripts. Those factors are involved in the processing of heterogeneous RNA to spliced mRNA in the nucleoplasm of all cells. The distribution of Rev was dependent only on Rev and host cell interactions, since neither the Rev target RNA nor other HIV proteins were expressed in the cells. Rev was found in the same subcellular compartments of cells treated for extended periods with cycloheximide, an inhibitor of protein synthesis. This finding implies that Rev shuttles continuously between cytoplasmic and nucleoplasmic compartments. The results suggest a potential role for Rev both in the RNA-splicing process and in the nucleocytoplasmic transport of Rev-dependent HIV mRNA. DE Amino Acid Sequence Antibodies, Monoclonal/BIOSYNTHESIS Antibody Specificity Autoantibodies Biological Transport *Cell Compartmentation Cell Nucleus/*CHEMISTRY/ULTRASTRUCTURE Cycloheximide/PHARMACOLOGY Fluorescent Antibody Technique Gene Products, rev/IMMUNOLOGY/*ISOLATION & PURIF Hela Cells Human HIV Antibodies/BIOSYNTHESIS HIV-1/*CHEMISTRY/IMMUNOLOGY Interphase/PHYSIOLOGY Molecular Sequence Data Ribonucleoproteins, Small Nuclear/ISOLATION & PURIF *RNA Splicing RNA, Small Nuclear/ISOLATION & PURIF Support, Non-U.S. Gov't Translation, Genetic/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).